News Related to Amyloid Precursor Protein

Related coverage linked through entity extraction aliases.

Anti-Epileptic Drug Levetiracetam Prevents Alzheimer's Amyloid-Beta Formation in Preclinical Study

Jul 15, 2026

A preclinical study shows that the anti-epileptic drug levetiracetam can prevent the formation of amyloid-beta 42 in neurons by modulating synaptic vesicle recycling. Analysis of patient records indicates a modest delay in cognitive decline among Alzheimer's patients taking the drug, suggesting potential for very early preventive use.

Alzheimer’s Disease in People With Down Syndrome: Risk, Timing and Screening

May 18, 2026

People with Down syndrome have a 90% to 95% lifetime risk of Alzheimer’s disease. Amyloid accumulation is almost inevitable by age 40, and baseline assessment is recommended by age 40 with annual follow-up.